Singapore pharmaceuticals association monitors US drug tariff developments
ReutersSep 26, 2025 10:51 AM
SINGAPORE, Sept 26 (Reuters) - Singapore's pharmaceutical industry association is monitoring developments closely, it said on Friday in response to U.S. plans to target the sector with a 100% tariff from next month.
U.S. President Donald Trump on Thursday announced 100% duties on imports of branded drugs.
Semiconductors, consumer electronics and pharmaceutical goods, account for about 40% of Singapore's exports to the United States, according to Singapore's central bank.
Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.
Related Articles
MicroStrategy (MSTR): Why This Bitcoin Proxy Is Decoupling From BTC — And Is It Still a Buy?
TradingKey - MicroStrategy stock is in a sustained decline and remains entrenched in a downward channel, as Bitcoin continues to fall and briefly dipped below $100,000 on November 4, leading to a sharp decline in Bitcoin-related stocks. We believe MicroStrategy’s slump has not yet abated.TradingKey
5 hours ago
Robinhood Q3 Earnings: Revenue Doubles, Profit Triples. So Why Did Markets Remain Cold?
TradingKey - Robinhood (HOOD), the zero-commission trading platform, posted record third-quarter 2025 earnings, with revenue soaring 100% and net profit nearly tripling. This stellar performance, fueled by robust trading activity and diversified business initiatives, significantly outpaced its rivalTradingKey
9 hours ago
U.S. Stock Market Opinions Diverge: Will the Market Rise or Fall Going Forward?
TradingKey - Since the beginning of 2025, the S&P 500 and Nasdaq Composite have risen approximately 15% and 21%, respectively. The primary drivers of this rally include the Federal Reserve’s ongoing rate cuts, optimism surrounding artificial intelligence, and robust corporate earnings growth.TradingKey
11 hours ago
Tesla’s 2025 Shareholder Meeting Showdown: Musk’s Leadership and Tesla’s Crossroads
TradingKey - Tesla (TSLA), the electric vehicle leader, will hold its 2025 Annual Shareholder Meeting on November 6. Dubbed by CEO Elon Musk as a moment that will “decide Tesla’s future and shape the world’s,” the event centers on one pivotal question: Will shareholders approve Musk’s proposed $1 TTradingKey
Wed, Nov 5
Palantir Q3 2025 Earnings: Blowout Performance Can’t Hide an AI Bubble， Four Growing Risks Behind a Nearly 1,000x Valuation
TradingKey – After the close of trading on November 4, “AI application King” Palantir Technologies (PLTR) reported its third-quarter earnings for fiscal year 2025. Despite a blowout quarter, surging top-line growth, and a flood of commercial orders, the stock plunged in after-hours trading.TradingKey
Tue, Nov 4
